3.145.46.4
dgid:
enl:
npi:0

Home Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease

Oculoplastics

Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease

Read More

By rd360stg

Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to FOCUS on Thyroid Eye Disease

By rd360stg

Mycophenolate mofetil appears to be effective second-line treatment for TED

By rd360stg

Teprotumumab improves clinical course of TED

By rd360stg

What is a Rainbow Brow?

By rd360stg

Anti-TNF alpha agents may be effective treatment for thyroid eye disease

By rd360stg

Is teprotumumab better than steroids in TED associated compressive optic neuropathy?

By rd360stg

Is deep sedation better than general anesthesia for some ophthalmology procedures?

By rd360stg

Patients with amblyopia who have neurodevelopmental delays have worse visual outcomes

By rd360stg

Retinoblastoma incidence rate increasing

By rd360stg

What is ‘Quiet’ Thyroid Eye Disease?

By rd360stg

Oxymetazoline hydrochloride 0.1% helps fill unmet need for patients with ptosis

By rd360stg

Thermal imaging useful in eyes with subtle clinical signs of TED

Videos

Gail Devers Partners with the Graves’ Community to Focus on Thyroid Eye Disease

15 Jul, 2021

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899

[email protected]

Social Links

© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved